Psilocybin 5 mg

DRUG2 trials

Sponsors

King's College London, Usona Institute

Conditions

Autism Spectrum DisorderDepressive Disorder, Major

Phase 3

Psilocybin for Major Depressive Disorder (MDD)

Active, not recruitingNCT06308653

Usona InstituteDepressive Disorder, Major

Start: 2024-03-13End: 2026-12-30Target: 240Updated: 2025-12-15

Unknown Phase

Psilocybin in Adults With and Without Autism Spectrum Disorder

CompletedNCT05651126

King's College LondonAutism Spectrum Disorder

Start: 2022-12-12End: 2024-08-23Updated: 2025-07-28

Related Papers

The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.

2024-04-251 citations